Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine (MindMed) Inc. - Common Shares (NQ:MNMD)

6.555 -0.045 (-0.68%)
Streaming Delayed Price Updated: 11:11 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine (MindMed) Inc. - Common Shares

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
Why Crypto-Related Stocks Are Trading Lower: Here Are 34 Stocks Moving Premarket
Gainers 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
  
Via Benzinga
EXCLUSIVE: $100M College Whiz Who Scored As Bed Bath And Beyond Squeezed Says He 'Wasn't That Aware It Was A Meme'
Jake Freeman, the 20-year-old college student who reportedly banked $100 million trading Bed Bath and Beyond stock, purchased 4.69 million shares of the retailer Bed Bath & Beyond Inc (NASDAQ: BBBY) in... 
Via Benzinga
Is MindMed (MNMD) Stock the Next Big Short Squeeze?
MNMD stock went through a short squeeze overnight, helped by a Cantor Fitzgerald recommendation and hope for LSD as a therapeutic. 
Via InvestorPlace
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. 
Via Benzinga
Study Suggests LSD May Boost Learning, Memory by Enhancing Neural Plasticity
Via Investor Brand Network
What Is Going on With Neptune Wellness (NEPT) Stock Today?
Neptune Wellness shares are rocketing higher, up more than 100% on the day. Here's what's driving NEPT stock higher on the day. 
Via InvestorPlace
Dow Falls 60 Points; Crude Oil Rises Sharply
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 60 points on Thursday. 
Via Benzinga
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. 
Via Benzinga
U.S. Stocks Turn Higher; Nasdaq Rises 50 Points
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 50 points on Thursday. 
Via Benzinga
MindMed A Newly Minted Meme? College Kid Who Made $100M On Bed Bath & Beyond Is Involved In Psychedelics Stock
A 20-year-old college student earned around $110 million after selling his stake in the troubled retailer Bed Bath & Beyond Inc (NASDAQ: BBBY) following the stock's recent rally of more than 339%,... 
Via Benzinga
What Is Going on With Vinco Ventures (BBIG) Stock Today?
Vinco Ventures (BBIG) stock is a big mover on Thursday as shares continue to rally after resuming trading earlier this week. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving! 
Via InvestorPlace
This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket
Gainers 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 17, 2022
  
Via Benzinga
Psychedelic Stock Gainers And Losers From August 16, 2022
  
Via Benzinga
HC Wainwright Slashes PT On This Stock By 50%; Here Are 5 Other Price Target Changes For Tuesday
HC Wainwright & Co. cut the price target on Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) from $10 to $5. HC Wainwright & Co. analyst Patrick Trucchio maintained the stock with a Buy rating. Mind... 
Via Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
  
Via Benzinga
Major Psychedelic Stocks Down This Week; Still Up Since End Of June
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then. 
Via Talk Markets
MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
MindMed (NASDAQ: MNMD), which recently received a letter on behalf of one of its shareholders calling for a new business strategy and offer 
Via Benzinga
Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today
  
Via Benzinga
Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today
  
Via Benzinga
What's Going On With MindMed? Co-Founder Dr. Scott Freeman Lays Out 'Value Enhancement Plan'
FCM MM Holdings sent a letter to MindMed’s (NASDAQ: MNMD) board of directors calling on them to adopt a new strategic plan to "turn the company around.” 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 10, 2022
  
Via Benzinga
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – August 10, 2022 – Toronto’s Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study... 
Via FinancialNewsMedia
Topics Supply Chain
Exposures Supply Chain
3 Best Psychedelic Stocks to Buy Now
These are three of the best psychedelic stocks to buy to get in on the next generation of treatment for mental health disorders. 
Via InvestorPlace
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today
  
Via Benzinga
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 
Via Benzinga
Key Biotech Company Goes All The Way To Reverse Share Split, Here's What We Know
Psychedelics appear to be here to stay. Yet stocks, shares and finance are another story. On August 4, publicly traded clinical-stage psychedelics firm Mind Medicine Inc. 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.